Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt® Eye Drops, 20 mg/mL + 5 mg/mL

NCT05973318 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open Angle Glaucoma of Both Eyes

Interventions

DRUG: Dorzotimol eye drops, 20 mg/mL + 5 mg/mL
DRUG: Cosopt eye drops, 20 mg/mL + 5 mg/mL

Sponsor

Jadran Galenski laboratorij d.d.